Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

The Kraft Group

Investor type Venture Capital
Founders Robert Kraft


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 39
Average round size
The average size of a deal this fund participated in
Portfolio companies 28
Rounds per year 0.78
Lead investments 3
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 7
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Biopharma
  • Medical Device

The Kraft Group is the famous Corporate Investor, which was founded in 1972. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the Boxborough.

This organization was formed by Robert Kraft.

Considering the real fund results, this Corporate Investor is 15 percentage points more often commits exit comparing to other organizations. The typical startup value when the investment from The Kraft Group is 500 millions - 1 billion dollars. The usual things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this The Kraft Group works on 7 percentage points less the average amount of lead investments. The top amount of exits for fund were in 2018. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2015.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the The Kraft Group, startups are often financed by North Bridge Venture Partners & Growth Equity, General Catalyst, Atlas Venture. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, SR One, Partners Innovation Fund. In the next rounds fund is usually obtained by Timothy A. Springer, SR One, Polaris Partners.

Among the most popular fund investment industries, there are Gaming, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight DraftKings, Acetylon Pharmaceuticals, Silk Therapeutics. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of The Kraft Group:
Typical Co-investors
The Kraft Group is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after The Kraft Group:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Big Pi Ventures Athens, Attiki, Greece
Convivialite Ventures California, San Francisco, United States
Creative Accelerator Csongrád-Csanád County, Hungary, Szeged
Deerfield Partners California, San Francisco, United States
Goal Ventures -
Goodmore Capital -
Grandland Group China, Guangdong, Shenzhen
Huaxin Capital China, Guangdong, Shenzhen
Huazhang Touzi Beijing, Beijing, China
IGrid Solutions Japan, Tokyo
Indicator Ventures New York, New York, United States
Jove Equity Partners East Setauket, New York, United States
NadiFin Dublin, Dublin, Ireland
Pine Labs India, Noida, Uttar Pradesh
Shanghai Ashe Investment Management China, Shanghai
Shenzhenshi Qianhai Derun Fujiang Touzi Guanli Co., Ltd. China, Guangdong, Shenzhen
Svensk Exportkredit Stockholm, Stockholm County, Sweden
The CDMN Soft-Landing Program Canada, Kitchener, Ontario
Xandr New York, New York, United States
Zhuhai Ailai Investment China, Guangdong, Zhuhai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


$3M03 Aug 2022 -

CAMP4 Therapeutics

$100M20 Jul 2022 Cambridge, Massachusetts, United States

Evolved By Nature

$120M28 Jun 2022 Massachusetts, United States

$35M22 Jun 2022 Herzliya, Tel Aviv, Israel

Relief App

Financial Services
$15M17 Feb 2022 Miami, Florida, United States


$12M20 Jan 2022 Newton, Massachusetts, United States

Evolved By Nature

$70M24 Dec 2021 Massachusetts, United States

Mythical Games

Video Games
$150M04 Nov 2021 Los Angeles, California, United States

CAMP4 Therapeutics

$45M15 Jun 2021 Cambridge, Massachusetts, United States
CAMP4 Raises $45 Million to Usher in a New Era of Programmable Therapeutics to Upregulate Genes

– CAMP4 Therapeutics announced that it has raised $45m to propel the next phase of its scientific strategy, significantly expand its platform and advance multiple preclinical RNA therapies into human testing.
– CAMP4 is combining its proprietary RNA Actuating Platform (RAP) with state-of-the-art oligonucleotide technology to develop precise and programmable therapeutics that enable tunable upregulation of gene expression to treat disease.
– CAMP4’s approach uniquely targets a new class of RNA known as regulatory RNAs (“regRNAs”) that control the expression of proteins, making this approach applicable to any genetic disease whereby a small increase in gene output can lead to meaningful therapeutic outcomes.
5AM Ventures and Northpond Ventures led the financing alongside existing investors Andreessen Horowitz, Polaris Partners and The Kraft Group.

River Financial ( raises $12M Series A to continue explosive growth of its Bitcoin financial services for traditional investors

– River Financial closed a $12m Series A equity financing round to continue growing its financial service offerings for traditional investors.
– The investment round was led by Goldcrest Capital with participation from Craft Ventures, Polychain Capital, M13, Castle Island, Slow Ventures, and The Kraft Group.
– River Financial previously announced a $5.7m seed round in June 2020.
– River’s client base has grown by almost 600% and order volumes have increased by 3,500%.
– River’s recent iOS app has accelerated the company’s growth, already accounting for over 30% of all River’s order volume within five weeks of launch.
– River Financial continues to experience exponential growth in new customers and order volume month-over-month as global interest in Bitcoin continues to grow rapidly.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent The Kraft Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: